Clinical Trials
6
Active:0
Completed:5
Trial Phases
4 Phases
Phase 2:1
Phase 3:1
Phase 4:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (33.3%)Phase 4
2 (33.3%)Phase 2
1 (16.7%)Phase 3
1 (16.7%)Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
Not Applicable
Recruiting
- Conditions
- Acne
- Interventions
- Drug: Topical Antioxidant SerumDevice: AviClear Laser
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Austin Institute for Clinical Research
- Target Recruit Count
- 10
- Registration Number
- NCT06376110
- Locations
- 🇺🇸
Austin Institute for Clinical Research, Inc., Pflugerville, Texas, United States
Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.
Phase 4
Completed
- Conditions
- Photoaging
- Interventions
- Device: LaseMD LaserDevice: Sciton LaserDrug: Phyto A+ Brightening Treatment
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Austin Institute for Clinical Research
- Target Recruit Count
- 38
- Registration Number
- NCT06090071
- Locations
- 🇺🇸
Austin Institute for Clinical Research, Inc., Pflugerville, Texas, United States
Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.
Phase 4
Completed
- Conditions
- Cutis Laxa FacialisXeroderma
- Interventions
- Device: HydraFacial Syndeo SystemDrug: ReGen-GFDevice: HydraFacial Elite MD System
- First Posted Date
- 2023-07-06
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Austin Institute for Clinical Research
- Target Recruit Count
- 27
- Registration Number
- NCT05932732
- Locations
- 🇺🇸
Austin Institute for Clinical Research, Inc., Pflugerville, Texas, United States
Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults
Not Applicable
Completed
- Conditions
- Photodamaged Skin
- Interventions
- Drug: Vitamin C with AHA Exfoliative SerumDrug: Placebo serum
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Austin Institute for Clinical Research
- Target Recruit Count
- 34
- Registration Number
- NCT05908825
- Locations
- 🇺🇸
Austin Institute for Clinical Research, Inc., Pflugerville, Texas, United States
Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults
Phase 2
Completed
- Conditions
- Superficial Basal Cell Carcinoma
- Interventions
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Austin Institute for Clinical Research
- Target Recruit Count
- 5
- Registration Number
- NCT05713760
- Locations
- 🇺🇸
Austin Institute for Clinical Research, Inc., Pflugerville, Texas, United States
- Prev
- 1
- 2
- Next
News
No news found